MedTrace Logo

Chronic Hepatitis B Virus Clinical Epidemiology in a Representative Sample of Zambian Adults

NCT03149627 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5003

Last updated 2026-01-21

No results posted yet for this study

Summary

The purpose of this study is to recruit a random and representative sample of individuals within several Zambian communities for markers of Hepatitis B Virus (HBV) and to characterize chronic HBV infection and indications for treatment.

Conditions

  • HBV
  • Alcoholic Hepatitis
  • Liver Fibroses

Interventions

OTHER

Estimates - prevalence of lifetime/chronic HBV infection

Estimation of the prevalence and correlates of lifetime HBV infection defined as hepatitis B core antibody (HBcAb) positivity and chronic HBV infection defined as HBsAg positivity.

Sponsors & Collaborators

  • University Teaching Hospital

    collaborator UNKNOWN

  • Tropical Gastroenterology and Nutrition Group

    collaborator UNKNOWN

  • Centre for Infectious Disease Research in Zambia

    collaborator OTHER

  • Ministry of Health, Zambia

    collaborator OTHER_GOV

  • University of Alabama at Birmingham

    lead OTHER

Principal Investigators

  • Michael J Vinikoor, MD · University of Alabama at Birmingham

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-07
Primary Completion
2018-12-19
Completion
2018-12-19

Countries

  • Zambia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03149627 on ClinicalTrials.gov